echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > UCSD: Refractory depression, a powerful option for magnetic convulsion therapy

    UCSD: Refractory depression, a powerful option for magnetic convulsion therapy

    • Last Update: 2021-11-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    In a new study published in the online edition of The Journal of Clinical Psychiatry on October 19, 2021, an international team of scientists led by Zafiris J.


    ECT is an operation performed under general anesthesia.


    ECT can be traced back to the 1930s


    ECT usually works when other treatments are unsuccessful, but it is not effective for everyone, and some side effects may still occur, such as confusion and memory loss


    MST is a different form of brain electrical stimulation that first appeared in the late 1990s



    Although in previous studies, both ECT and MST (to a lesser extent) have shown immediate results in the treatment of at least some cases of acute or refractory depression, whether sustained MST can prevent mental illness We know very little about recurrence


    In the latest similar study, Daskalakis and his colleagues investigated whether continued use of MST can prevent the recurrence of refractory (unipolar) major depression or bipolar depression, including symptoms of mania


    The researchers recruited participants who qualified for the diagnosis and responded well to the acute phase of MST to receive continuous MST treatment


    One-third of patients experienced depression relapse or required mental hospitalization, and there was no significant difference between unipolar and bipolar depression patients


    The authors note that the recurrence rate of persistent MST is lower than that of studies that evaluated early one-time acute MST: 33% vs.


    The author said that the scale of this study is small, but the results of the study are encouraging enough to conduct larger-scale clinical trials, especially comparing the efficacy of MST and ECT


    Victor M.




    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.